Pfizer’s Motion to Dismiss the Brook Jackson, federal contracting fraud, clinical trial fraud, whistleblower case.
Brook Jackson is the Ventavia clinical trials manager who contacted FDA in September 2020 to report egregious violations of standard clinical trial and patient safety procedures at two of the Texas sites where Ventavia employees, as subcontractors to Pfizer, were recruiting human subjects and administering Pfizer’s products throughout Summer 2020.
FDA ignored her reports about the dangerous conditions in the clinics, and reported her whistleblower contact to Pfizer.
Pfizer sicced fixer attorney Mark Barnes on Jackson in October 2020.
In January 2021, Jackson filed a federal complaint under the False Claims Act, through the US Department of Justice, in the US District Court, Eastern Texas. (1:21-cv-00008-MJT)
DOJ and the federal judge stalled the case and gagged Jackson from speaking publicly during the American mass injection rollout from January to November 2021.
When Pfizer and the FDA came for American children (FDA announced ‘approval’ for injecting kids ages 5-11 on Oct. 29, 2021), Jackson violated the gag order to go public in a British Medical Journal report by Paul Thacker published Nov. 2, 2021.
Pfizer filed a Motion to Dismiss Jackson’s case on April 22, 2022, arguing:
“Because of pandemic-related exigencies, the agreement was not a standard federal procurement contract, but rather a ‘prototype’ agreement executed pursuant to 10 U.S.C. § 2371b[.]…
The [contract’s Statement of Work] describes a ‘large scale vaccine manufacturing demonstration’ that imposes no requirements relating to Good Clinical Practices (‘GCP’) or related FDA regulations.”
This is court-filed, under-oath corroboration that Pfizer and FDA are jointly engaged in a domestic bioterrorism program against the American people, operated by US-HHS and US-DOD on behalf of the World Health Organization, falsely presented as a public health campaign.
And that neither Pfizer nor FDA ever believed anyone had a legal or moral obligation to protect the safety of the people taking the injections, from the very start of the faked clinical trials to the present.